RESUMEN
Human leukocyte antigen (HLA)-G is an immune checkpoint molecule that is highly expressed in papillary thyroid carcinoma (PTC). The HLA-G gene presents several functional polymorphisms distributed across the coding and regulatory regions (5'URR: 5' upstream regulatory region and 3'UTR: 3' untranslated region) and some of them may impact HLA-G expression and human malignancy. To understand the contribution of the HLA-G genetic background in PTC, we studied the HLA-G gene variability in PTC patients in association with tumor morbidity, HLA-G tissue expression, and plasma soluble (sHLA-G) levels. We evaluated 185 PTC patients and 154 healthy controls. Polymorphic sites defining coding, regulatory and extended haplotypes were characterized by sequencing analyses. HLA-G tissue expression and plasma soluble HLA-G levels were evaluated by immunohistochemistry and ELISA, respectively. Compared to the controls, the G0104a(5'URR)G*01:04:04(coding)UTR-03(3'UTR) extended haplotype was underrepresented in the PTC patients, while G0104a(5'URR)G*01:04:01(coding)UTR-03(3'UTR) was less frequent in patients with metastatic and multifocal tumors. Decreased HLA-G tissue expression and undetectable plasma sHLA-G were associated with the G010102a(5'URR)G*01:01:02:01(coding)UTR-02(3'UTR) extended haplotype. We concluded that the HLA-G variability was associated with PTC development and morbidity, as well as the magnitude of the encoded protein expression at local and systemic levels.
Asunto(s)
Antígenos HLA-G , Neoplasias de la Tiroides , Humanos , Cáncer Papilar Tiroideo/genética , Antígenos HLA-G/genética , Regiones no Traducidas 3' , Morbilidad , Neoplasias de la Tiroides/genética , Proteínas de Unión al GTPRESUMEN
Chagas disease is a parasitic disease from South America, affecting around 7 million people worldwide. Decades after the infection, 30% of people develop chronic forms, including Chronic Chagas Cardiomyopathy (CCC), for which no treatment exists. Two stages characterized this form: the moderate form, characterized by a heart ejection fraction (EF) ≥ 0.4, and the severe form, associated to an EF < 0.4. We propose two sets of DNA methylation biomarkers which can predict in blood CCC occurrence, and CCC stage. This analysis, based on machine learning algorithms, makes predictions with more than 95% accuracy in a test cohort. Beyond their predictive capacity, these CpGs are located near genes involved in the immune response, the nervous system, ion transport or ATP synthesis, pathways known to be deregulated in CCCs. Among these genes, some are also differentially expressed in heart tissues. Interestingly, the CpGs of interest are tagged to genes mainly involved in nervous and ionic processes. Given the close link between methylation and gene expression, these lists of CpGs promise to be not only good biomarkers, but also good indicators of key elements in the development of this pathology.
Asunto(s)
Cardiomiopatía Chagásica , Enfermedad de Chagas , Adenosina Trifosfato/metabolismo , Biomarcadores/metabolismo , Cardiomiopatía Chagásica/diagnóstico , Cardiomiopatía Chagásica/genética , Enfermedad de Chagas/genética , Metilación de ADN , HumanosRESUMEN
Chagas disease, caused by the protozoan Trypanosoma cruzi, is an endemic parasitic disease of Latin America, affecting 7 million people. Although most patients are asymptomatic, 30% develop complications, including the often-fatal Chronic Chagasic Cardiomyopathy (CCC). Although previous studies have demonstrated some genetic deregulations associated with CCCs, the causes of their deregulations remain poorly described. Based on bulk RNA-seq and whole genome DNA methylation data, we investigated the genetic and epigenetic deregulations present in the moderate and severe stages of CCC. Analysis of heart tissue gene expression profile allowed us to identify 1407 differentially expressed transcripts (DEGs) specific from CCC patients. A tissue DNA methylation analysis done on the same tissue has permitted the identification of 92 regulatory Differentially Methylated Regions (DMR) localized in the promoter of DEGs. An in-depth study of the transcription factors binding sites (TFBS) in the DMRs corroborated the importance of TFBS's DNA methylation for gene expression in CCC myocardium. TBX21, RUNX3 and EBF1 are the transcription factors whose binding motif appears to be affected by DNA methylation in the largest number of genes. By combining both transcriptomic and methylomic analysis on heart tissue, and methylomic analysis on blood, 4 biological processes affected by severe CCC have been identified, including immune response, ion transport, cardiac muscle processes and nervous system. An additional study on blood methylation of moderate CCC samples put forward the importance of ion transport and nervous system in the development of the disease.
Asunto(s)
Cardiomiopatía Chagásica , Enfermedad de Chagas , Trypanosoma cruzi , Enfermedad de Chagas/genética , Epigénesis Genética , Humanos , Factores de Transcripción/genéticaRESUMEN
Hepatitis C virus usually produces chronic infection and liver damage. Considering that: i) the human leukocyte antigen-E (HLA-E) molecule may modulate the immune response, and ii) little is known about the role of HLA-E gene variability on chronic hepatitis C, we studied the impact of HLA-E polymorphisms on the magnitude of HLA-E liver expression and severity of hepatitis C. HLA-E variability was evaluated in terms of: i) single nucleotide polymorphism (SNP) alleles and genotypes along the gene (beginning of the promoter region, coding region and 3'UTR), and ii) ensemble of SNPs that defines the coding region alleles, considered individually or as genotypes. The comparisons of the HLA-E variation sites between patients and controls revealed no significant results. The HLA-E + 424 T > C (rs1059510), +756 G > A (rs1264457) and + 3777 G > A (rs1059655) variation sites and the HLA-E*01:01:01:01 and HLA-E*01:03:02:01 alleles, considered at single or double doses, were associated with the magnitude of HLA-E liver expression in Kupfer cell, steatosis, inflammatory activity and liver fibrosis. Although these associations were lost after corrections for multiple comparisons, these variable sites may propitiate biological clues for the understanding of the mechanisms associated with hepatitis C severity.
Asunto(s)
Genotipo , Hepacivirus/fisiología , Hepatitis C Crónica/genética , Antígenos de Histocompatibilidad Clase I/genética , Hígado/metabolismo , Adulto , Anciano , Progresión de la Enfermedad , Femenino , Regulación de la Expresión Génica , Frecuencia de los Genes , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Antígenos de Histocompatibilidad Clase I/metabolismo , Humanos , Hígado/patología , Masculino , Persona de Mediana Edad , Polimorfismo de Nucleótido Simple , Adulto Joven , Antígenos HLA-ERESUMEN
Chagas disease is caused by the protozoan parasite Trypanosoma cruzi. During the chronic phase of disease, while most infected people do not present symptoms, characterizing the asymptomatic form, some patients develop the cardiac form or chronic chagasic cardiomyopathy, which is considered the most severe manifestation of this disease. Considering that the activation of the PI3Kγ signaling pathway is essential for an efficient immune response against T. cruzi infection, we evaluated the PIK3CG C > T (rs1129293) polymorphism in exon 3 of this gene, which encodes the catalytic subunit of PI3Kγ. The PIK3CG CT and TT genotypes were found to be associated with an increased risk of developing the cardiac form of the disease rather than the asymptomatic or digestive forms. In conclusion, the presence of the T allele at single or double doses may differentiate the cardiac from other clinical manifestations of Chagas disease. This finding should help in further studies to evaluate the mechanisms underlying the differential association of PIK3CG in Chagas disease.
Asunto(s)
Dominio Catalítico/genética , Cardiomiopatía Chagásica/genética , Enfermedad de Chagas/genética , Enfermedad de Chagas/parasitología , Fosfatidilinositol 3-Quinasa Clase Ib/genética , Polimorfismo de Nucleótido Simple , Trypanosoma cruzi , Cardiomiopatía Chagásica/parasitología , Fosfatidilinositol 3-Quinasa Clase Ib/metabolismo , Variación Genética , Genotipo , Corazón/parasitología , Interacciones Huésped-Parásitos , Humanos , Enfermedades Desatendidas/genética , Enfermedades Desatendidas/parasitología , Transducción de SeñalRESUMEN
[This corrects the article DOI: 10.3389/fimmu.2020.01386.].
RESUMEN
Background: Chagas disease, caused by the protozoan Trypanosoma cruzi, is endemic in Latin America. Thirty percent of infected individuals develop chronic Chagas cardiomyopathy (CCC), an inflammatory dilated cardiomyopathy that is the most important clinical consequence of T. cruzi infection, while the others remain asymptomatic (ASY). IFN-γ and IFN-γ-producing Th1-type T cells are increased in peripheral blood and CCC myocardium as compared to ASY patients, while the Th1-antagonizing cytokine IL-10 is more expressed in ASY patients. Importantly IFN-γ-producing Th1-type T cells are the most frequent cytokine-producing T cell subset in CCC myocardium, while expression of Th1-antagonizing cytokines IL-10 and IL-4 is unaltered. The control of IFN-γ production by Th1-type T cells may be a key event for progression toward CCC. A genetic component to disease progression was suggested by the familial aggregation of cases and the association of gene polymorphisms with CCC development. We here investigate the role of gene polymorphisms (SNPs) in several genes involved in the control of IFN-γ production and Th1 T cell differentiation in CCC development. Methods: We studied a Brazilian population including 315 CCC cases and 118 ASY subjects. We assessed 35 Tag SNPs designed to represent all the genetic information contained in the IL12B, IL10, IFNG, and IL4 genes. Results: We found 2 IL12 SNPs (rs2546893, rs919766) and a trend of association for a IL10 SNP (rs3024496) to be significantly associated with the ASY group. these associations were confirmed by multivariate analysis and allele tests. The rs919766C, 12rs2546893G, and rs3024496C alleles were associated to an increase risk to CCC development. Conclusions: Our data show that novel polymorphisms affecting IL12B and IL10, but not IFNG or IL4 genes play a role in genetic susceptibility to CCC development. This might indicate that the increased Th1 differentiation and IFN-γ production associated with CCC is genetically controlled.
Asunto(s)
Cardiomiopatía Chagásica/genética , Interleucina-10/genética , Subunidad p40 de la Interleucina-12/genética , Diferenciación Celular , Cardiomiopatía Chagásica/inmunología , Enfermedad Crónica , Progresión de la Enfermedad , Predisposición Genética a la Enfermedad , Interferón gamma/biosíntesis , Interferón gamma/genética , Interleucina-4/genética , Polimorfismo de Nucleótido Simple , Células TH1/inmunologíaRESUMEN
BACKGROUND: Increasing evidence shows that chronic inflammation plays an important role in thyroid tumorigenesis. Cytokines as central mediators in inflammatory microenvironment can present both pro-tumour and anti-tumour effects and cytokine release may be influenced by soluble HLA-G (sHLA-G), an immune checkpoint molecule whose expression can also be induced by certain cytokines. AIM: To understand the role of these soluble factors in papillary thyroid cancer (PTC). METHODS: We evaluated plasma levels of sHLA-G and of 13 cytokines using ELISA and flow cytometry, respectively, in PTC patients at two time points: pre- and post-thyroidectomy; and control subjects. RESULTS: Compared with controls, IL-6 levels were increased, while IL-1ß, IFN-α and TGF-ß1 levels were decreased in pre-thyroidectomy PTC patients. IFN-α and TGF-ß1 efficiently discriminated patients from controls and were associated with extrathyroidal extension and lymph node metastasis, respectively. In addition, TNF and IL-13 were associated with male gender, lymph node metastasis and Hashimoto thyroiditis, and sHLA-G with tumour invasion. Compared with pre-thyroidectomy, IL-4, IL-10, TNF, IFN-α and TGF-ß1 levels were increased in post-thyroidectomy. CONCLUSION: There are significant changes in the cytokine profile after surgical removal of the thyroid tumour, and IFN-α e TGF-ß1 showed to be promising cytokines for discriminating PTC patients from controls. We also found that different cytokines are associated with clinicohistopathological characteristics of PTC related to poor prognosis, suggesting that cytokines seem to play an important role in PTC development and management.
Asunto(s)
Carcinoma Papilar/metabolismo , Citocinas/sangre , Antígenos HLA-G/sangre , Cáncer Papilar Tiroideo/metabolismo , Adulto , Biomarcadores/metabolismo , Carcinoma Papilar/patología , Carcinoma Papilar/cirugía , Estudios de Casos y Controles , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pronóstico , Estudios Retrospectivos , Cáncer Papilar Tiroideo/patología , Cáncer Papilar Tiroideo/cirugía , TiroidectomíaRESUMEN
Chronic hepatitis C virus (HCV) infection induces liver damage and the HCV/Human Immunodeficiency Virus (HIV)-coinfection may further contribute to its progression. The HLA-G molecule inhibits innate and adaptive immunity and may be deleterious for chronically virus-infected cells. Thus we studied 204 HCV-mono-infected patients, 142 HCV/HIV-coinfected patients, 104 HIV-mono-infected patients and 163 healthy subjects. HLA-G liver expression was similarly induced in HCV and HCV/HIV specimens, increasing with advanced fibrosis and necroinflammatory activity, and with increased levels of liver function-related enzymes. Plasma soluble HLA-G (sHLA-G) levels were higher in HCV/HIV patients compared to HCV, HIV and to healthy individuals. sHLA-G continued to be higher in coinfected patients even after stratification of samples according to degree of liver fibrosis and necroinflammatory activity when compared to mono-infected patients. Some HLA-G gene haplotypes differentiated patient groups and presented few associations with liver and plasma HLA-G expression. HLA-G thus may help to distinguish patient groups.
Asunto(s)
Infecciones por VIH/inmunología , Antígenos HLA-G/genética , Antígenos HLA-G/metabolismo , Hepatitis C Crónica/inmunología , Hígado/metabolismo , Adulto , Coinfección , Femenino , Regulación de la Expresión Génica/genética , Regulación de la Expresión Génica/inmunología , VIH-1/inmunología , Haplotipos/genética , Hepacivirus/inmunología , Humanos , Masculino , Persona de Mediana Edad , Polimorfismo Genético/genética , Estudios RetrospectivosRESUMEN
BACKGROUND: Little information is available regarding the expression of the immunomodulatory Human Leukocyte Antigen (HLA)-G and -E molecules in pancreatic disorders. AIM: To analyze HLA-G and -E expression in specimens of alcoholic chronic pancreatitis (ACP), idiopathic chronic pancreatitis (ICP), type 1 (T1D) and type 2 diabetes (T2D) and in histologically normal pancreas (HNP). METHODS: HLA-G and -E expression (ACPâ¯=â¯30, ICPâ¯=â¯10, T1Dâ¯=â¯10, T2Dâ¯=â¯30 and HNPâ¯=â¯20) was evaluated by immunohistochemistry in three different areas (acini, islets and inflammatory infiltrate). RESULTS: Acini and islets from HNP specimens exhibited higher HLA-G and -E expression compared to corresponding areas from all other patient groups. In inflammatory infiltrate, HLA-G and -E expression was observed only among the pancreatic disorders. We observed higher HLA-G and -E expression in acini from T2D compared to ACP, as well as higher HLA-G expression compared to ICP. CONCLUSION: The decreased expression of HLA-G and -E in islets and acini together with the expression of these molecules in the inflammatory infiltrating cells were shared features among chronic inflammatory and autoimmune pancreatic disorders evaluated in this study, possibly reflecting tissue damage.
Asunto(s)
Células Acinares/metabolismo , Diabetes Mellitus Tipo 1/inmunología , Diabetes Mellitus Tipo 2/inmunología , Antígenos HLA-G/metabolismo , Antígenos de Histocompatibilidad Clase I/metabolismo , Islotes Pancreáticos/patología , Pancreatitis Alcohólica/inmunología , Células Cultivadas , Enfermedad Crónica , Regulación hacia Abajo , Regulación de la Expresión Génica , Humanos , Inmunohistoquímica , Inflamación , Antígenos HLA-ERESUMEN
Hepatitis C virus (HCV) can escape from innate and adaptive immunity, making the immune response ineffective. Human leukocyte antigen E (HLA-E) might regulate the antiviral function of immune response and contribute to the persistence of HCV and the severity of liver disease. This study aimed to evaluate the expression of HLA-E in the liver and its association with the severity of liver disease in HCV patients. We performed a retrospective analysis of liver biopsies from 125 HCV patients and from 20 control subjects without liver disease. Liver biopsies were reviewed and classified according to severity of fibrosis and inflammatory activity. The pathologist assessed the magnitude of HLA-E expression in a semiquantitative way, attributing scores from 0 to 3. Immunohistochemistry showed positive for HLA-E in hepatocyte and Kupffer cells. The rate of HLA-E positivity in hepatocytes and Kupffer cells was significantly higher in HCV patients compared to controls. The liver samples classified as severe fibrosis and necroinflammatory activity presented greater expression of HLA-E on Kupffer cells and hepatocytes, with a significant linear association. It indicates that HLA-E expression may have an immunomodulatory effect and a possible role in the severity of liver disease in chronic hepatitis C.
Asunto(s)
Expresión Génica , Hepatitis C Crónica/genética , Antígenos de Histocompatibilidad Clase I/genética , Adulto , Anciano , Biopsia , Femenino , Hepacivirus/inmunología , Hepatitis C Crónica/diagnóstico , Hepatitis C Crónica/inmunología , Hepatitis C Crónica/virología , Hepatocitos/metabolismo , Hepatocitos/patología , Antígenos de Histocompatibilidad Clase I/inmunología , Humanos , Inmunohistoquímica , Macrófagos del Hígado/metabolismo , Hígado/inmunología , Hígado/metabolismo , Hígado/patología , Hígado/virología , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Antígenos HLA-ERESUMEN
Chagas disease is caused by infection with the protozoan Trypanosoma cruzi (T. cruzi) and is an important cause of severe inflammatory heart disease. However, the mechanisms driving Chagas disease cardiomyopathy have not been completely elucidated. Here, we show that the canonical PI3Kγ pathway is upregulated in both human chagasic hearts and hearts of acutely infected mice. PI3Kγ-deficient mice and mutant mice carrying catalytically inactive PI3Kγ are more susceptible to T. cruzi infection. The canonical PI3Kγ signaling in myeloid cells is essential to restrict T. cruzi heart parasitism and ultimately to avoid myocarditis, heart damage, and death of mice. Furthermore, high PIK3CG expression correlates with low parasitism in human Chagas' hearts. In conclusion, these results indicate an essential role of the canonical PI3Kγ signaling pathway in the control of T. cruzi infection, providing further insight into the molecular mechanisms involved in the pathophysiology of chagasic heart disease.
Asunto(s)
Cardiomiopatía Chagásica/inmunología , Fosfatidilinositol 3-Quinasa Clase Ib/metabolismo , Transducción de Señal/inmunología , Trypanosoma cruzi/inmunología , Adulto , Animales , Biopsia , Línea Celular , Cardiomiopatía Chagásica/parasitología , Cardiomiopatía Chagásica/patología , Fosfatidilinositol 3-Quinasa Clase Ib/genética , Modelos Animales de Enfermedad , Femenino , Corazón/parasitología , Humanos , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Persona de Mediana Edad , Células Mieloides/inmunología , Células Mieloides/metabolismo , Miocardio/inmunología , Miocardio/patología , Inhibidores de las Quinasa Fosfoinosítidos-3 , Quinoxalinas/farmacología , Tiazolidinedionas/farmacología , Trypanosoma cruzi/patogenicidad , Regulación hacia ArribaRESUMEN
The HLA-G 5'URR extending 1.4 kb from the ATG presents a unique set of regulatory elements among HLA genes. Several variable sites have been described that coincide with or are close to these elements, thus HLA-G 5'URR polymorphism might influence the HLA-G expression level. We cloned the ten most frequent HLA-G 5'URR haplotypes to evaluate their activity on a luciferase reporter gene in HLA-G+ cell lines (JEG-3/choriocarcinoma and FON+/melanoma). We also investigated associations between the plasma HLA-G (sHLA-G) levels and the HLA-G 5'URR variability in 157 healthy individuals. Cell lines were transfected with pGL3-Basic vector constructions containing HLA-G 5'URR sequences. The G010101a (in JEG-3) and G010101b (in FON+) haplotypes exhibited higher promoter activity, whereas the G010101d (in JEG-3) and G010102a (in FON+) haplotypes exhibited lower promoter activity. In the presence of HLA-G inducers (interferon-ß and progesterone) or repressors (cyclopamine) HLA-G promoter activity was modulated, but certain haplotypes exhibited differential responses. No strict association was observed between plasma sHLA-G levels and the 5'URR haplotypes or genotypes; however, the G010101b haplotype was underrepresented among HLA-G-negative plasmas. Therefore, the HLA-G 5'URR polymorphism may have an impact on the modulation of HLA-G gene expression, but alone provides a limited predictive value for sHLA-G levels in vivo.
Asunto(s)
Regiones no Traducidas 5'/genética , Microambiente Celular , Antígenos HLA-G/genética , Haplotipos , Polimorfismo de Nucleótido Simple , Secuencias Reguladoras de Ácidos Nucleicos , Factores de Transcripción/metabolismo , Adulto , Coriocarcinoma/genética , Coriocarcinoma/patología , Femenino , Genotipo , Antígenos HLA-G/metabolismo , Humanos , Masculino , Melanoma/genética , Melanoma/patología , Células Tumorales CultivadasRESUMEN
BACKGROUND: Human African trypanosomiasis (HAT) caused by Trypanosoma brucei gambiense can be diagnosed in the early hemolymphatic stage (stage 1 [S1]) or meningoencephalitic stage (stage 2 [S2]). Importantly, individuals harbouring high and specific antibody responses to Tbg antigens but negative parasitology are also diagnosed in the field (seropositive [SERO]). Whereas some develop the disease in the months following their initial diagnosis (SERO/HAT), others remain parasitologically negative for long periods (SERO) and are apparently able to control infection. Human leucocyte antigen (HLA)-G, an immunosuppressive molecule, could play a critical role in this variability of progression between infection and disease. METHODS: Soluble HLA-G (sHLA-G) was measured in plasma for patients in the SERO (n = 65), SERO/HAT (n = 14), or HAT (n = 268) group and in cerebrospinal fluid for patients in S1 (n = 55), early S2 (n = 93), or late S2 (n = 110). Associations between these different statuses and the soluble level or genetic polymorphisms of HLA-G were explored. RESULTS: Plasma sHLA-G levels were significantly higher in HAT (P = 6 × 10-7) and SERO/HAT (P = .007) than SERO patients. No difference was observed between the SERO/HAT and HAT groups. Within the HAT group, specific haplotypes (HG010102 and HG0103) displayed increased frequencies in S1 (P = .013) and late S2 (P = .036), respectively. CONCLUSIONS: These results strongly suggest the involvement of HLA-G in HAT disease progression. Importantly, high plasma sHLA-G levels in SERO patients could be predictive of subsequent disease development and could represent a serological marker to help guide therapeutic decision making. Further studies are necessary to assess the predictive nature of HLA-G and to estimate both sensitivity and specificity.
Asunto(s)
Antígenos HLA-G/sangre , Tripanosomiasis Africana/sangre , Adulto , Biomarcadores/sangre , Progresión de la Enfermedad , Femenino , Haplotipos , Humanos , Masculino , Pronóstico , Trypanosoma brucei gambiense , Tripanosomiasis Africana/fisiopatología , Tripanosomiasis Africana/prevención & controlRESUMEN
Objetivo: Investigar a prevalência do aleitamento cruzado e os saberes sobre esta prática, entre gestantes atendidasna Estratégia Saúde da Família (ESF), do município de Belém, estado do Pará. Método: foi realizada uma pesquisaquanti-qualitativa, com desenho de estudo descritivo, observacional do tipo transversal. Os participantes da pesquisase constituíram de 85 gestantes atendidas nas ESF Galo I, Galo II e Canal da Visconde. Os dados foram coletadosatravés da aplicação de questionário semi-estruturado, aplicados entre os meses de setembro a novembro de 2013.Resultados: a prevalência de aleitamento cruzado encontrada foi de 61,54% entre as mulheres que já tinham filhos, amaioria das gestantes entrevistadas amamentaria o filho de outra pessoa caso fosse solicitada sem qualquer restrição,bem como pediriam para outra mulher amamentar seu filho caso achasse necessário. Um grande percentual (94,87%)de entrevistadas presenciou o aleitamento cruzado. Praticamente todas as gestantes relataram que não receberaminformação sobre os riscos do aleitamento cruzado pela equipe de saúde durante a realização do pré-natal. Os motivosque justificaram a prática do aleitamento cruzado foram: a dificuldade para amamentar e a ausência temporária oudefinitiva da mãe. Conclusão: as concepções históricas culturalmente estabelecidas sobre o aleitamento materno,o sentimento de solidariedade, o altruísmo entre as mães, o incentivo ao aleitamento materno sem enfatizar suascontraindicações, em conjunto com a carência de informações sobre os riscos do aleitamento, se configuraram nestapesquisa como os principais motivos para a prática do aleitamento cruzado
Objective: to investigate the prevalence of crossed breast feeding and knowledge about this practice, among thepregnant women assisted in the Family?s Health Strategy of the municipal district of Belem, state of Para. Methods:a quantitative and qualitative research was accomplished, with drawing of descriptive, observational and crosssectionalstudy type. The subjects of the research were 85 pregnant women assisted in PSF Galo I, Galo II e Canal daVisconde. The data were collected through the application of semi-structured questionnaire, applied among monthsof September to November of 2013. Results: The prevalence of crossed breast feeding found was 61,54% amongwomen that already had children, most of the pregnant women interviewees would breastfeed the son of anotherperson case it was requested without any restriction, as well as they would ask for another woman to breastfeed his/her son if necessary. A big one percentile (94, 87%) of interviewees witnessed the crossed breast feeding. Practicallyall the pregnant women told they did not receive information about the risks of breast feeding crossed by the team ofhealth during the accomplishment of the prenatal. The reasons that justified the crossed breast feedingpractice were:the difficulty to breastfeed and the temporary or definitivemother's absence. Conclusion: the historical conceptionsculturally established on the maternal breast feeding, the solidarity feeling, the altruism among the mothers, theincentive to maternal breast feeding without emphasizing its contraindications, together with the lack of informationon the risks of breast feeding, were configured in this research as the main reasons for the practice of the crossedbreast feeding.
RESUMEN
HLA-E is a non-classical Human Leucocyte Antigen class I gene with immunomodulatory properties. Whereas HLA-E expression usually occurs at low levels, it is widely distributed amongst human tissues, has the ability to bind self and non-self antigens and to interact with NK cells and T lymphocytes, being important for immunosurveillance and also for fighting against infections. HLA-E is usually the most conserved locus among all class I genes. However, most of the previous studies evaluating HLA-E variability sequenced only a few exons or genotyped known polymorphisms. Here we report a strategy to evaluate HLA-E variability by next-generation sequencing (NGS) that might be used to other HLA loci and present the HLA-E haplotype diversity considering the segment encoding the entire HLA-E mRNA (including 5'UTR, introns and the 3'UTR) in two African population samples, Susu from Guinea-Conakry and Lobi from Burkina Faso. Our results indicate that (a) the HLA-E gene is indeed conserved, encoding mainly two different protein molecules; (b) Africans do present several unknown HLA-E alleles presenting synonymous mutations; (c) the HLA-E 3'UTR is quite polymorphic and (d) haplotypes in the HLA-E 3'UTR are in close association with HLA-E coding alleles. NGS has proved to be an important tool on data generation for future studies evaluating variability in non-classical MHC genes.
Asunto(s)
Regiones no Traducidas 3' , Población Negra/genética , Variación Genética , Secuenciación de Nucleótidos de Alto Rendimiento/métodos , Antígenos de Histocompatibilidad Clase I/genética , Prueba de Histocompatibilidad , Sistemas de Lectura Abierta , África Occidental , Alelos , Frecuencia de los Genes , Genética de Población , Haplotipos , Humanos , Desequilibrio de Ligamiento , Polimorfismo de Nucleótido Simple , Análisis de Secuencia de ADN , Antígenos HLA-ERESUMEN
BACKGROUND: Chronic Chagas Disease cardiomyopathy (CCC), a life-threatening inflammatory dilated cardiomyopathy, affects 30% of the approximately 8 million patients infected by Trypanosoma cruzi, the rest of the infected subjects remaining asymptomatic (ASY). The Th1 T cell-rich myocarditis plays a pivotal role in CCC pathogenesis. Local expression of IL-18 in CCC myocardial tissue has recently been described. IL-18 could potentially amplify the process by inducing increased expression of IFN-γ which in turn can increase the production of IL-18, thereby creating a positive feedback mechanism. In order to assess the contribution of the IL-18 to susceptibility to Chronic Chagas Disease, we investigated the association between a single nucleotide polymorphism (SNP) located in the IL-18 gene with the risk of developing Chagas cardiomyopathy. METHODS AND RESULTS: We analyzed the rs2043055 marker in the IL18 gene in a cohort of Chagas disease cardiomyopathy patients (n=849) and asymptomatic subjects (n=202). We found a significant difference in genotype frequencies among moderate and severe CCC patients with ventricular dysfunction. CONCLUSIONS: Our analysis suggests that the IL18 rs2043055 polymorphism- or a SNP in tight linkage disequilibrium with it- may contribute to modulating the Chagas cardiomyopathy outcome.
Asunto(s)
Cardiomiopatía Chagásica/genética , Predisposición Genética a la Enfermedad , Interleucina-18/genética , Polimorfismo de Nucleótido Simple/genética , Estudios de Casos y Controles , Cardiomiopatía Chagásica/fisiopatología , Enfermedad Crónica , Estudios de Cohortes , Femenino , Estudios de Asociación Genética , Humanos , Masculino , Volumen SistólicoRESUMEN
Considering that the non-classical HLA-G molecule has well-recognized tolerogenic properties, HLA-G expression is expected to be deleterious when present in tumor cells and in cells chronically infected by viruses, whereas HLA-G expression is expected to be advantageous in autoimmune disorders. The expression of HLA-G on tissue or peripheral blood cells, the levels of soluble HLA-G and polymorphic sites along the gene have been studied in several disorders. In this study, we revised the role of the molecule and polymorphic sites along the HLA-G gene in tumors, viral hepatitis, and parasitic disorders. Overall, several lines of evidence clearly show that the induction of HLA-G expression in tumors has been associated with worse disease outcome and disease spread. In addition, the few studies conducted on hepatitis and parasitic disorders indicate that HLA-G may contribute to disease pathogenesis. Few isolated polymorphic sites, primarily located at the coding or 3' untranslated HLA-G region, have been evaluated in these disorders, and a complete HLA-G typing together with the study of gene regulatory elements may further help on the understanding of the influence of the genetic background on disease susceptibility.